Intelligence Platform
Patents
Browse 88 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6933274
Methods for treatment of diabetes using a peptide analogues of insulin
expired patentUS 6890518
Compositions of chemically modified insulin
expired patentUS 6838076
Pulmonary administration of chemically modified insulin
expired patentUS 6770276
Insulin-containing medicament for peroral application and method for the production thereo
expired patentUS 6737045
Methods and compositions for the pulmonary delivery insulin
expired patentUS 6685967
Methods and compositions for pulmonary delivery of insulin
expired patentUS 6562942
Methods for treatment of diabetes using peptide analogues of insulin
expired patentUS 6511811
Protein kinase C antagonist related to insulin receptor
expired patentUS 6468959
Peroral dosage form for peptide containing medicaments, in particular insulin
expired patentUS 6448045
Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1
expired patentUS 6391651
Materials and methods for detection of insulin dependent diabetes
expired patentUS 6319495
Method for restoring glucose responsiveness to insulin secretion
expired patentUS 6207159
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
expired patentUS 6197926
Methods for treatment of diabetes using peptide analogues of insulin
expired patentUS 6071891
Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells compositio
expired patentUS 6022697
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
expired